Wall Street raises STAAR Surgical price target to $40 on Q1 beat: STAA rally analysis
2026-05-14 10:42:23 ET
More on STAAR Surgical
- STAAR Surgical Company (STAA) Q1 2026 Earnings Call Transcript
- STAAR Surgical: Q1 Preliminary Revenues Justify Decision To Reject Alcon Bid
- STAAR Surgical: Despite Promises Of Improvement, Investors Should Stay Cautious
- STAAR Surgical rises on Q1 beat; Wedbush upgrades on China recovery
- STAAR targets about 75% gross margin and $225M 2026 spend as Switzerland plans to supply 100% of China lenses
Read the full article on Seeking Alpha
For further details see:
Wall Street raises STAAR Surgical price target to $40 on Q1 beat: STAA rally analysisNASDAQ: STAA
STAA Trading
13.55% G/L:
$32.93 Last:
2,312,641 Volume:
$35.77 Open:



